4//SEC Filing
Wilson Martin 4
Accession 0001140361-25-034422
CIK 0001281895other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 4:18 PM ET
Size
4.9 KB
Accession
0001140361-25-034422
Insider Transaction Report
Form 4
Wilson Martin
General Counsel
Transactions
- Award
Common Stock
2025-09-08+150,000→ 285,462 total
Footnotes (2)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- [F2]Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on September 8, 2026, with the remaining shares vesting in equal quarterly installments over the following two years.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001704342
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 4:18 PM ET
- Size
- 4.9 KB